Niacin receptor agonists, compositions containing such compounds and methods of treatment

Details for Australian Patent Application No. 2006285064 (hide)

Owner Merck & Co., Inc.

Inventors Tata, James R.; Colletti, Steven L.; Szymonifka, Michael J.; Shen, Hong

Agent Spruson & Ferguson

Pub. Number AU-A-2006285064

PCT Pub. Number WO2007/027532

Priority 60/712,275 29.08.05 US

Filing date 25 August 2006

Wipo publication date 8 March 2007

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/027532 Priority application(s): WO2007/027532

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285077-Anti-microbial catheter

2006285062-Modified landplaster as a wallboard filler